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an introduction to automated flow 
cytometry gating tools and their 
implementation
Chris P. Verschoor, Alina Lelic, Jonathan L. Bramson and Dawn M. E. Bowdish*
Department of Pathology and Molecular Medicine, McMaster Immunology Research Centre (MIRC), McMaster University, 
Hamilton, ON, Canada
Current flow cytometry (FCM) reagents and instrumentation allow for the measurement 
of an unprecedented number of parameters for any given cell within a homogenous 
or heterogeneous population. While this provides a great deal of power for hypothesis 
testing, it also generates a vast amount of data, which is typically analyzed manually 
through a processing called “gating.” For large experiments, such as high-content 
screens, in which many parameters are measured, the time required for manual analysis 
as well as the technical variability inherent to manual gating can increase dramatically, 
even becoming prohibitive depending on the clinical or research goal. In the following 
article, we aim to provide the reader an overview of automated FCM analysis as well as 
an example of the implementation of FLOw Clustering without K, a tool that we con-
sider accessible to researchers of all levels of computational expertise. In most cases, 
computational assistance methods are more reproducible and much faster than manual 
gating, and for some, also allow for the discovery of cellular populations that might not 
be expected or evident to the researcher. We urge any researcher who is planning or has 
previously performed large FCM experiments to consider implementing computational 
assistance into their analysis pipeline.
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introduction
Recent advances in flow cytometry (FCM) have provided researchers in the fields of cellular and 
clinical immunology an incredible amount of leverage toward testing new hypotheses. These include 
improvements to reagents and instrumentation employed in traditional fluorescence-based FCM, 
allowing for the measurement of up to 20 parameters for any given cell (1), as well as the introduction 
of mass cytometry [CyTOF, reviewed in Ref. (2)], which can measure up to 34 parameters for any 
given cell. These technologies, while allowing for the discrimination of new and sometimes rare 
populations within a heterogeneous mixture of cells (akin to a needle in a haystack), also produce a 
tremendous amount of data, which is most commonly analyzed manually using proprietary software 
(for example, FlowJo)1. For many immunologists, the manual analysis of FCM data does not hinder 
productivity, given that most FCM experiments are performed on a small number (<40) of experi-
mental units and involve less than a half dozen parameters. However, in the case of experiments 
that require the interrogation of more than 10 parameters in hundreds of experimental units, the 
1 www.flowjo.com
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manual analysis of FCM can become a significant expenditure of 
time. For example, our laboratory group has performed a number 
of studies on the frequency and phenotype of peripheral blood 
 leukocytes (white blood cells) in elderly individuals, discrimi-
nating up to 16 cell surface and intracellular molecules (across 
multiple stains) in 130 to more than a 1000 individuals (3–7). 
For any one of these studies, the time required for FCM analysis 
alone was >15 h.
In the following review, we will provide an overview of the 
methods to automate FCM analysis computationally and describe 
one of the more accessible solutions available to researchers 
with little or no experience in computer programing. We urge 
any researcher who has conducted or is considering conducting 
a large-scale FCM study to evaluate these tools as well as many 
of the other exquisite techniques that are freely available to the 
scientific community.
an overview of Flow Cytometry
Invented in the 1960s, and first described in 1972 (8), FCM or 
fluorescence-activated cell sorting (FACS), as it was first called, 
has transformed a number of fields, most of which being cellular 
and clinical immunology. It allows for the quantification of either 
surface or intracellularly expressed molecules (also known as 
antigens) for a single cell within a larger population, doing so in a 
high-throughput fashion, providing measurements for hundreds 
to thousands of cells per second. FCM is particularly useful in sit-
uations in which the researcher wishes to discriminate between 
multiple different cell types within a heterogeneous population 
and measure their individual frequencies or the expression of 
a specific molecule of interest (Figure 1). For example, FCM is 
often used to measure the frequency of two major T-lymphocyte 
populations in the peripheral blood, T helper cells and cytotoxic 
T-cells, which is easily accomplished by distinguishing leukocytes 
according to the expression of the cell-surface molecules CD4 
(T helper cell) and CD8 (cytotoxic T-cell) (Figure 1). In many 
clinical studies, FCM has proved to be indispensable, allowing for 
the measurement of distinct, sometimes rare populations of cells 
that are indicative of the progression of disease (9) or the success 
of therapeutic intervention (10).
Gating
One of the most basic principles of FCM analysis is “gating,” 
which is the sequential identification and refinement of a cellular 
population of interest using a panel of molecules (also known as 
markers) that are visualized by fluorescence in a unique emission 
FiGUre 1 | a brief overview of a flow cytometry experiment identifying 
the proportions of t helper and cytotoxic t-lymphocytes in human 
peripheral blood. Peripheral blood leukocytes are first stained with three 
antibodies conjugated to unique fluorescent dyes (not represented here), 
which will specifically bind the T-lymphocyte markers (antigens) CD3, CD4, or 
CD8. This sample of leukocytes is then transferred to the flow cytometer’s flow 
cell, which focuses the stream of leukocytes, allowing them to pass through 
the laser beam one at a time. The fluorescent dyes are then excited by the 
laser, and their emitted spectrum is detected by sensors, which digitize the 
information and visualizes it as two-dimensional dot plots, or one-dimensional 
histograms. The levels of CD3, CD4, and CD8 are recorded for every 
leukocyte that passes through the flow cell, therefore, allowing for the 
quantification of frequency of CD3+CD4+ T helper or CD3+CD8+ cytotoxic 
T-lymphocytes.
FiGUre 2 | an example of a gating strategy used to identify Cd4+ t 
helper and Cd8+ cytotoxic t-lymphocytes in human peripheral blood. 
Antibodies that specifically recognize the cell-surface markers CD45, CD14, 
CD15, CD3, CD19, CD4, and CD8, and conjugated to the fluorescent dyes 
AmCyan, Pacific Blue, Allophycocyanin (APC), APC Cy7, Alexa Fluor 700, 
PerCp Cy5.5, and PE Cy7, respectively, were used to sequentially identify 
T-lymphocytes expressing CD45, CD3, and CD4 or CD8, while excluding cells 
expressing CD14 (monocytes), CD15 (neutrophils), or CD19 (B-lymphocytes).
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spectrum. For example, if a researcher is interested in quantify-
ing the proportions of CD4 expressing T helper cells and CD8 
expressing cytotoxic T-cells in peripheral blood, he/she may use 
a combination of antibodies (which specifically recognize the 
marker of interest) conjugated to unique fluorescent dyes that 
will accurately identify these cells, while discriminating other 
cell types that are not of interest. In the example of Figure  2, 
the cells of interest that are being selected (gated) express CD45 
(a pan-leukocyte marker), CD3 (a marker specific to mainly 
T-lymphocytes), and CD4, or CD8. Cells that are not of interest 
and will be “gated out” also express CD45, but uniquely express 
CD14 (commonly expressed on monocytes), CD15 (commonly 
expressed on neutrophils), or CD19 (commonly expressed on 
B-lymphocytes). Thus, according to the fluorescence of dyes 
conjugated to antibodies recognizing each marker, the researcher 
will be able to identify T helper cells and cytotoxic T-cells, which 
may also be labeled CD45+CD14−CD15−CD19−CD3+CD4+CD8− 
and CD45+CD14−CD15−CD19−CD3+CD4−CD8+, respectively. 
Additionally, based on the level of fluorescence for a given 
marker, the researcher can also measure the degree to which that 
molecule is being expressed by the cell of interest.
Computational assistance for  
FCM analysis
Why you should Consider Using  
Computational assistance Methods
One of the three primary reasons that researchers should consider 
implementing computational assistance for their FCM analysis is 
speed. As previously mentioned, the time it takes to manually 
analyze an FCM experiment is dependent on the number of 
experimental units to process as well as the number of markers 
(also known as parameters) needed to gate. This can increase the 
analysis time dramatically if the gating strategy is particularly 
complex. Depending on the particular software package used, the 
use of computational assistance can reduce FCM analysis time 
from hours to minutes (11).
The inherent subjectivity of manual analysis should be 
considered another major reason for the use of computational 
assistance for FCM analysis. Since manual analysis requires 
the user to specify which cells to gate on (often called a “gating 
strategy”), additional technical variation will naturally arise 
due to the inability of humans to accurately reproduce this 
strategy within and across FCM experiments. The amount of 
technical variability related to human subjectivity, not surpris-
ingly, is increased if more than one user is tasked to perform 
the FCM analysis, and has been estimated to be as high as 78% 
(12, 13). Computational assistance not only removes the neces-
sity for multiple individuals to take part in FCM analysis but 
also compared to manual gating, many software packages have 
been shown to be vastly superior with regards to the variability 
observed due to the gating procedure, even when applied to 
experiments performed with heterogeneous protocols and 
reagents (13–15).
Finally, another great benefit to the use of computational 
assistance for FCM analysis is the potential to discover new, 
biologically relevant cellular populations that were not initially 
considered by the researcher. As previously discussed, the basis 
of manual analysis is a gating strategy that allows one to capture 
data for particular cellular populations of interest. Computational 
methods are efficient “discovery” tools because they do not rely 
on any particular gating strategy or guidance from the end-user 
to identify cellular populations in FCM experiments. Instead, 
they apply mathematical algorithms that are able to detect trends 
within an entire FCM dataset, which are inferred to be bona fide 
cellular populations. Hence, populations that were not specified 
in a given gating strategy may be identified by computational 
analysis. That being said, upon discovering a new cellular 
population, it is still necessary for researchers to validate their 
finding biologically. Most computational methods are unable to 
distinguish between true fluorescence due to marker expression 
and artifactual fluorescence due to cellular autofluorescence or 
fluorescent spillover (16), and some will simply overestimate 
the number of cellular populations without guidance from the 
end-user (17).
FiGUre 3 | Biological and technical variability between flow cytometry 
(FCM) experiments. Four separate experiments, performed on different days 
with peripheral blood mononuclear cells from at least two different donors 
demonstrates the variability in the fluorescent staining patterns that is common in 
FCM analysis. FCM 1–3 represent experiments performed on different donors over 
different days. FCM 3 and 4 represent the same donor analyzed on different days.
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an overview of some of the procedures Used by 
Computational assistance software packages
Dozens of freely available software packages have been reported 
[see Ref. (11, 18)], and can be categorized anywhere from being 
completely automated without the need for guidance from the 
end-user, to being partially automated and requiring a great 
deal of guidance and adjustment (tuning) in order to complete 
its task. The basis of these packages, which allow them to adapt 
to experimental environments that often include a great deal of 
technical and biological variability (Figure 3), is the algorithms 
and mathematical procedures upon which they are built. Below is 
a brief summary of these approaches, including inherent advan-
tages and disadvantages.
According to Bashashati and Brinkman (18), there are five 
distinct requirements for an automated gating procedure: (1) 
computational efficiency, (2) the ability to identify a cellular 
population regardless of shape, (3) robustness toward different 
antigen/marker densities and expression patterns, (4) the abil-
ity to determine the true population number accurately, and 
(5) the ability to detect and account for outliers. All of these 
requirements essentially surround the capacity of the software 
to correctly identify clusters or groups of data points, which are 
assumed to be bona fide cellular populations. While there are 
many approaches to do this, the most common use clustering 
algorithms, with k-means clustering being the most popular, and 
model-based algorithms.
k-Means clustering is an iterative process in which “k” number 
of clusters are defined (often by the user) and the center of each 
cluster (initially assigned randomly) is refined until each cluster 
encompasses a unique set of data points; in other words, each 
FCM data point ends up being closest to only one cluster center. 
Naturally, the clusters tend to center in areas of density, which 
are assumed to be cellular populations (19). Major limitations 
of conventional k-means clustering with regards to automated 
FCM analysis is that the user must specify “k,” the number of 
clusters needed to be identified, and it is restricted to identifying 
spherically shaped populations (19). However, k-means is also a 
relatively fast procedure, which provides an important advantage 
over other automated gating algorithms. Some software pack-
ages [for example, flowMeans (20)] attempt to circumvent the 
drawback of a priori cluster specification by first computationally 
identifying the maximal number of clusters in a given FCM 
dataset, then iteratively collapsing that number by merging those 
clusters that significantly overlap.
As an alternative to clustering approaches, such as k-means, 
model-based approaches are attractive given that they are robust 
to the shape of cellular populations and do not require a priori 
input as does k-means clustering. However, these benefits come 
at a computational cost, and therefore, model-based approaches 
can be very time consuming (21). The most common approach 
is Gaussian, which requires FCM fluorescence data to follow a 
normal distribution, while others, such as t, skew-t, and uniform, 
offer more flexibility in this regard (18, 20). Some software pack-
ages use a combinational approach including k-means clustering 
and model-based algorithms to maximize efficiency and accuracy 
[for example, flowPeaks (22)], while others include hierarchical 
clustering in their combined approach [for example, Citrus (23) 
and Spade (24)].
One of the most recently published software packages, 
flowDensity (25), offers a different approach. Instead of using 
clustering or model-based approaches to identify cellular 
populations, the software employs a manual gating strategy. 
This approach sacrifices the discovery aspect of automated FCM 
analysis, but benefits greatly in computational efficiency and the 
ability to accurately measure rare cellular populations, since they 
are effectively pre-defined by the end-user. Unlike many other 
packages, this software, as well as that of Feher and colleagues 
(16), can also make use of fluorescent-minus one (FMO) controls. 
An FMO is an important control for manual gating analysis in 
which a replicate FCM experiment is processed that includes 
all but one of the conjugated antibodies in the staining cocktail. 
Hence, the FMO provides the end-user an empirically derived 
fluorescence cut-off for the missing antibody’s respective dye. 
Software packages that incorporate FMO controls are expected 
to offer enhanced accuracy with regards to the measurement of 
rare cellular populations or those that are defined by markers that 
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present as a continuous expression pattern (i.e., a smear, as in 
CD28 in Figure 4A, right panels).
As alluded to above, the approach of a given software pack-
age can have a major effect on its overall performance. To shed 
light on this issue in a standardized and unbiased manner, the 
flow cytometry: critical assessment of population identification 
methods (FlowCap) consortium was formed (11).
Flow Cytometry: Critical assessment of 
population identification Methods
The FlowCap consortium represents leaders in the areas of math-
ematics, statistics, biology, and software development with the 
primary goal to objectively test and compare FCM computational 
assistance software and provide guidance on the best use of the 
available algorithms. To this date, the consortium has performed 
two competitions: FlowCap I, in which software packages were 
compared against manual gating under various levels of adjust-
ment and tuning by the end-user, and FlowCap II, in which the 
ability of the software to define cellular populations that could 
then be used to stratify biological samples was tested. The results 
of these competitions can be found in Aghaeepour et al. (11).
For the FlowCap I competition, 14 software packages were 
employed to analyze 5 different FCM datasets submitted by 
experts in the fields of medicine and immunology, and their results 
compared against those derived from manual gating. Scores were 
presented using an f-score, where a score of 1 indicates that a 
particular software package perfectly mimics manual gating. In 
the first challenge, software packages were tested without any user 
guidance. From this, seven packages were observed to have an 
f-score of 0.80–0.90, the top four of which being ADICyt (com-
mercially available from Adinis Ltd., Slovakia), flowMeans (20), 
FLAME (27), and FLOw Clustering without K (FLOCK) (28). 
Interestingly, manual tuning or adjustment of software analysis 
settings by the end-user only marginally improved the f-score 
of each package tested. However, if the number of identified 
populations desired by the end-user were used as guidance, the 
f-scores improved dramatically, with five algorithms ending up 
with scores of 0.90 or greater. As before, this not only included 
ADIcyt, FlowMeans, and FLOCK but also SamSpectral (29) and 
TCLUST (30). The overall conclusion from this challenge was 
that although some packages performed better than others, most 
performed well and this was largely dependent on the dataset 
analyzed. Furthermore, it was also observed that combining the 
results of multiple software packages (referred to as ensembl 
clustering) consistently performed best for all challenges, as high 
as 0.97, in fact.
For the second FlowCap competition, a series of software 
packages were tested for their ability to stratify a cohort of indi-
viduals into different classification groups based on their FCM 
data. This differs from the first challenge in that the particular 
cellular populations identified were not of interest, rather the 
software’s ability to identify populations that are highly corre-
lated to a classification group (i.e., diseased or not diseased). The 
results from this challenge indicate that most packages are very 
good predictors of sample classification, and, in some cases, the 
software was perfect in its prediction. The results imply that using 
computational assistance will likely be an ideal fit for a clinical 
laboratory that relies on FCM for the diagnosis of patient health. 
However, the authors stress that the predictive capacity of these 
software packages is highly dependent on the nature of classifica-
tion. In other words, for diseases in which FCM markers are not 
useful for diagnosis, computational assistance will provide little 
to no benefit.
implementation of automated FCM 
analysis for immunologists
A major roadblock to the widespread implementation of auto-
mated FCM gating approaches is the perception by the scientific 
community that a great deal of technical expertise is required 
to operate them (31). While this is true for some software pack-
ages, many exist that can be easily and quickly employed by any 
researcher with access to the internet.
Flow cytometry analysis software can be broadly grouped into 
two areas: those driven by graphical-user interfaces (GUIs), which 
can be controlled by mouse and simple keyboard commands, and 
command-line driven modules, which require at least some com-
puter programing language expertise. The former are commonly 
run from online servers or as stand-alone software, while the latter 
most commonly require proficiency in the programing language 
R2, an open-source and free-to-use software environment that 
has applications for a myriad of analyses in physical, biological, 
and social sciences. For those who are interested in learning R, 
there are a number of free-to-use, interactive online courses that 
can provide most individuals with enough proficiency to operate 
FCM analysis packages programed in this language; for example, 
Datacamp3 or Code School4.
For those who have not employed computation assistance 
for their FCM analyses, we will briefly introduce FLOCK (28), 
a software package that is easily accessible by most researchers. 
Using a small FCM dataset, we will compare the results from 
FLOCK using guidance free and tuned settings to manual gating 
as a frame of reference.
FLow Clustering Without K
FLOw Clustering without K was chosen because of its excellent 
performance in the FlowCap challenges (11) and represents an 
automated FCM analysis package that does not require any com-
puter programing expertise, instead running from the publically 
available Immunology Database and Analysis Portal (Immport) 
(32) from the National Institute of Allergy and Infectious 
Diseases (NIAID). Furthermore, FLOCK does not require any 
manual adjustment to operate, although user adjustments are 
possible. FLOCK’s approach to identify cellular populations in 
an FCM experiment is grid-based partitioning of the data fol-
lowed by density distribution analysis. In density distribution 
analysis, dense clusters of cells are identified and assigned a label 
at their center (known as a centroid), which can then be used to 
identify those same cellular clusters in other FCM experiments. 
Consequently, it is these two steps that users are able to manually 
2 http://cran.r-project.org/
3 https://www.datacamp.com
4 tryr.codeschool.com
FiGUre 4 | a graphical comparison of cellular populations identified by 
manual gating and FLoCK. (a) The gating strategy for manual analysis to 
sequentially identify the proportion of CD4 and CD8 expressing CD3+ 
lymphocytes, as well as the frequency of those that also express CD28. Note: 
the percentages shown represent the frequency of cells relative to the parent 
gate. FLOCK analysis was performed in parallel under (B) completely 
automated (no guidance) conditions as well as with (C) manual adjustment to 
the analysis parameters (bin = 30, density = 25). Each color represents a 
different cellular population as determined by FLOCK. Data employed have 
been previously published using a different analysis by Lelic et al. (26).
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adjust in order to refine their results; first, the number of bins 
(6–30), which specifies the degree to which the FCM environ-
ment is partitioned, and second, the density threshold cut-off 
(6–100), which modulates how the software determines whether 
two adjacent cellular clusters are one in the same or separate enti-
ties. There is also an automated mode where these two parameters 
are determined by the algorithm empirically. Many FCM results 
can be compared to each other after a canonical set of centroids 
is chosen by the user.
A major advantage of using FLOCK is that even though the 
user is able to manually tune the results, no guidance by way 
of a gating strategy is required. Hence, FLOCK can be very 
useful for identifying cellular populations that the researcher 
was not initially intending to measure. Another major 
advantage is its ease of implantation. A user can register with 
ImmPort, upload their FCM dataset (as FCS or text format), 
and perform FLOCK analysis in less than thirty minutes. 
Furthermore, the time to analyze a single FCM experiment 
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file is trivial (minutes, for most experiments). A disadvantage 
of FLOCK, as shown in our example below, is that without 
manual tuning, FLOCK has a tendency to overestimate the 
number of cellular populations in a given FCM dataset. This, 
of course, is dependent on the particular dataset, which can 
vary greatly with regards to its heterogeneity and the number 
of parameters measured.
implementing FLoCK for automated FCM 
dataset analysis
To provide an example of FLOCK analysis, we analyzed a subset 
of FCM experiments from a previously published study (26). In 
this study, peripheral blood mononuclear cells from individuals 
aged 19–85 years old and acutely infected with West Nile virus 
(WNV) and chronically infected with Epstein–Barr virus (EBV) 
were tested for their ability to respond to peptides derived from 
these viruses. For the current analysis, a subset of 42 individuals 
were randomly chosen and the frequency of CD3+, CD3+CD4+, 
CD3+CD8+, CD3+CD4+CD28+, and CD3+CD8+CD28+ lym-
phocytes were measured by manual gating (Figure  4A) and 
FLOCK, under completely automated (Figure  4B) as well as 
manually tuned (Figure  4C) settings. Traditionally, the pres-
ence of these four markers on lymphocytes are discriminated as 
either expressed (+) or not expressed (−). Manual gating was 
performed using FlowJo, and simple comparison by Spearman’s 
rank correlation was performed to judge the performance of 
FLOCK.
Under completely automated settings FLOCK performed very 
quickly as compared to manual gating (23 min as compared to 
~1 h), and as expected, the software also estimated more cellular 
populations than expected, 30 (Table 1). It should be noted that 
this includes a number of populations that would not be consid-
ered in the manual gating strategy (which is designed to measure 
only five populations), and includes cells that do not express CD3 
or CD28, and those that express neither CD4 nor CD8. However, 
in addition to the conventional expression patterns for these 
five markers, either expressed (+) or not expressed (−), FLOCK 
also specifies “low” expressing populations (i.e., CD3lo) for each 
marker. This dramatically increases the number of populations 
identified. Although it is possible that a “low” expression pattern 
for CD3, CD4, CD8, or CD28 expressing lymphocytes is biologi-
cally relevant as opposed to an artifact of the FLOCK analysis, it 
is less likely that all 30 cellular populations are biologically and 
functionally distinct.
To reduce the resulting cellular populations identified 
to a number that is more likely to be biologically relevant, 
we adjusted the analysis parameters for FLOCK. This was 
determined on a fairly arbitrary basis, increasing the “bin” 
and “density” values until the number of cellular populations 
identified were no more than three times what is specified by 
our manual gating strategy. Using a bin value of 30 and a density 
value of 15, FLOCK identified 12 populations, which included 
“+,” “−,” and “lo” designations (Table 1). Further inspection of 
these populations indicated that as compared to the design of 
our manual gating strategy, FLOCK perceived the following: 
CD3+ cells included those labeled as CD3+ or CD3lo; CD4+ cells 
included those labeled as CD4loCD8− and CD4+CD8lo; CD8+ 
cells included those labeled as CD8loCD4− and CD8+CD4−; 
and CD28+ cells were either CD28lo or CD28+, and no CD28− 
cells were identified (Table 1). When the frequencies of those 
populations were combined into groups matching that in our 
manual gating strategy, and compared to our manual analysis 
using Spearman’s rank correlation, we found that the results 
from FLOCK are very similar. The ρ correlation for the CD3+, 
CD3+CD4+, CD3+CD4+CD28+, and CD3+CD8+ populations 
were 0.97, 0.96, 0.93, and 0.92, respectively, and significant at 
p < 0.0001 (Table 2). FLOCK estimated a higher frequency of 
cells in the CD3+CD8+CD28+ population, but was still compa-
rable and significant (ρ = 0.62, p < 0.0001, Table 2).
This brief comparison demonstrates the power of using 
FLOCK, namely the ability to identify cellular populations that 
were not specified in the manual gating strategy, the reduced time 
expenditure, and the high level of comparability to the results 
determined by manual analysis. The relatively lower correlation 
for the CD3+CD8+CD28+ population indicates that a software 
package may not be equally comparable to manual gating for all 
populations measured, and suggests that significant tuning of 
the analysis parameters may be required before a researcher is 
confident in the final analysis performed.
taBLe 1 | Cellular populations identified in our sample FCM dataset by 
manual gating and analysis by FLoCK.
Manual gating FLoCK (completely 
automated)
FLoCK (manual tuning)
CD3+ a CD3−CD4loCD8−CD28lo CD3−CD4loCD8−CD28−
CD3+CD4+ b CD3−CD4−CD8−CD28lo CD3loCD4loCD8−CD28lo a,b
CD3+CD4+CD28+ c CD3+CD4+CD8loCD28+ CD3+CD4loCD8−CD28+ a,b,c
CD3+CD8+ d CD3−CD4loCD8−CD28lo CD3−CD4loCD8−CD28lo
CD3+CD8+CD28+ e CD3loCD4−CD8−CD28lo CD3loCD4−CD8+CD28lo a,d
CD3−CD4+CD8−CD28− CD3+CD4−CD8loCD28+ a,d
CD3−CD4+CD8−CD28lo CD3−CD4+CD8−CD28lo
CD3−CD4+CD8−CD28lo CD3−CD4+CD8−CD28−
CD3+CD4loCD8−CD28+ CD3−CD4+CD8−CD28lo
CD3+CD4−CD8loCD28+ CD3+CD4+CD8loCD28+ a,b,c
CD3+CD4loCD8loCD28+ CD3+CD4loCD8loCD28+ a
CD3−CD4loCD8−CD28lo CD3+CD4−CD8+CD28lo a,d,e
CD3−CD4−CD8−CD28−
CD3loCD4loCD8−CD28lo
CD3+CD4+CD8−CD28+
CD3+CD4−CD8loCD28+
CD3−CD4+CD8−CD28−
CD3+CD4loCD8loCD28lo
CD3loCD4loCD8−CD28lo
CD3−CD4+CD8−CD28lo
CD3−CD4+CD8−CD28−
CD3+CD4loCD8loCD28+
CD3+CD4loCD8loCD28+
CD3−CD4+CD8−CD28lo
CD3−CD4loCD8loCD28lo
CD3+CD4loCD8+CD28lo
CD3+CD4loCD8+CD28+
CD3+CD4−CD8+CD28lo
CD3loCD4−CD8+CD28−
CD3loCD4−CD8+CD28lo
Populations in the manual gating and FLOCK (manual tuning) groups with matching 
superscripts were combined within group and used to compare analysis methods.
Data employed have been previously published using a different analysis by Lelic 
et al. (26).
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Conclusion
In conclusion, we have provided an overview of automated FCM 
analysis as well as its advantages and disadvantages as compared 
to manual gating. There are numerous software packages to 
choose from, all of which differing slightly in the benefits they 
can provide to a given FCM dataset, as well as the technical 
expertise required to operate them. In our example we describe 
the results from FLOCK, a software package requiring little to no 
computing programing experience, and demonstrate the power 
of automated gating to improve the time required FCM analysis. 
Furthermore, our results from FLOCK demonstrate the potential 
for computational assistance to discover new, not previously 
taBLe 2 | summary statistics and correlations of a paralleled analysis by manual gating and FLoCK (manually tuned).
Cd3+ Cd4+ Cd4+Cd28+ Cd8+ Cd8+Cd28+
Manual Flock Manual Flock Manual Flock Manual Flock Manual Flock
Average 84.2 78.1 52.9 50.3 49.6 48.7 21.9 24.0 9.0 16.2
SE 1.4 1.7 2.7 2.2 2.7 2.4 1.6 1.5 0.7 1.1
25th Percentile 79.6 74.7 45.3 42.6 41.8 41.4 14.6 18.1 6.0 10.1
75th Percentile 91.3 85.7 63.5 60.9 59.7 58.5 26.4 27.0 10.8 20.3
Spearman’s ρ* 0.97 0.96 0.93 0.92 0.62
An FCM dataset of peripheral blood mononuclear cells from 42 individuals was analyzed to identify the proportion (relative to the total lymphoid population) of CD4 and CD8 
expressing CD3+ lymphocytes, as well as the frequency of those that also express CD28. Data employed have been previously published using a different analysis by Lelic et al. (26).
*Significance of all Spearman’s rank correlations was p < 0.0001.
considered cellular populations in a given FCM dataset. We urge 
any researcher who is planning or has previously performed 
large FCM experiments to consider implementing computational 
assistance into their analysis pipeline.
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